Steroid-growth factor interaction in human prostate cancer. 2. Effects of transforming growth factors on androgen metabolism of prostate cancer cells

Steroids

Volumn 61, Issue 1, 1996, Pages 41-46

  Carruba, Giuseppe ^c   Granata, Orazia M ^a   Farruggio, Rosaria ^c   Cannella, Sonia ^c   Lo Bue, Arianna ^c   Leake, Robin E ^c   Pavone Macaluso, Michele ^c   Castagnetta, Luigi A M ^a,b  

^a Ospedale Oncologico M Ascoli   (Italy)

^b Experimental Oncology   (Italy)

^c NONE

Author keywords

androgen; cell lines; metabolism; prostate cancer; transforming growth factors

Indexed keywords

ANDROSTANEDIONE; ANDROSTERONE; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR;

ANDROGEN METABOLISM; ARTICLE; CANCER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PROSTATE CANCER; PROSTATE DISEASE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STEROID METABOLISM; TESTOSTERONE BLOOD LEVEL;

EID: 0030064866     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0039-128X(95)00174-O     Document Type: Article

References (24)

1. Bartsch W, Klein H, Schiemann U, Bauer HW, Voigt KD (1990). Enzymes of androgen formation and degradation in the human prostate. Ann NY Acad Sci 595:53-66.
2. Klein H, Bressel M, Kastendieck H, Voigt KD (1991). Biochemical endocrinology of prostate cancer. In: Voigt KD, Knabbe C (eds), Endocrine-Dependent Tumors, Raven Press, New York, pp. 131-163.
3. Orlowski J, Clark AF (1991). Epithelial-stromal interactions in the regulation of rat ventral prostate function: identification and characterization of pathways for androgen metabolism in isolated cells. Endocrinology 128:872-884.
4. Geller J, Albert JD (1985). DHT in prostate cancer tissue - a guide to management and therapy. The Prostate 6:19-25.
5. Castagnetta L, Granata OM, Polito L, Blasi L, Cannella S, Carruba G (1994). Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells. J Steroid Biochem Mol Biol 49:351-357.
6. Carruba G, Leake RE, Rinaldi F, Chalmers D, Comito L, Sorci C, Pavone-Macaluso M, Castagnetta L (1994). Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells. Steroids 59:412-420.
7. Castagnetta L, Carruba G, Granata OM, Lo Casto M, Arcuri F, Mesiti M, Pavone-Macaluso M (1990). Prostate long-term epithelial cell lines: biological and biochemical features. Ann NY Acad Sci 595:149-164.
8. D'Agostino G, Mitchell F, Castagnetta L, O'Hare MJ (1984). Solvent optimization of reversed-phase high-performance liquid chromatography for polar adrenal steroids using computer-predicted retention. J Chromatogr 305:13-26.
9. D'Agostino G, Castagnetta L, Mitchell F, O'Hare MJ (1985). Computer-aided mobile phase optimization and chromatogram simulation in high-performance liquid chromatography. J Chromatogr 338:1-23.
10. Castagnetta L, Granata OM, Lo Casto M, Mitchell F, D'Agostino G, O'Hare MJ (1986). Steroids profiles and optimization of high-performance liquid chromatographic analytic procedure. Ann NY Acad Sci 464:316-330.
11. Castagnetta L, Granata OM, Lo Casto M, Calabrò M, Arcuri F, Carruba G (1991). A simple approach to measure metabolic pathways of steroids in living cells. J Chromatogr 572:25-39.
12. Smith CM, Ballard SA, Wyllie MG, Masters JRW (1994). Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro. J Steroid Biochem Mol Biol 50:151-159.
13. Guillemette C, Belanger A (1995). Glucuronosyltransferase activity in human cancer cell line LNCaP. Mol Cell Endocrinol 107:131-139.
14. Wilding G, Valverius E, Knabbe C, Gelmann EP (1989). The role of transforming growth factor-α in human prostate cancer cell growth. The Prostate 15:1-12.
15. Schuurmans ALG, Bolt J, Mulder E (1988). Androgens stimulate both growth-rate and epidermal growth factor receptor activity of the human prostate tumor cell line LNCaP. The Prostate 12:55-64.
16. Kyprianou N, Isaacs JT (1988). Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgens. Endocrinology 123:2124-2131.
17. Kyprianou N, Isaacs JT (1989). Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 3:1515-1522.
18. Carruba G 1994. Paracrine regulation of human prostate cancer cell growth and function. PhD Thesis, University of Glasgow.
19. Castagnetta L, Carruba G (1995). Human prostate cancer: a direct role for oestrogens. In: J Goode (ed), Non-Reproductive Actions of Sex Steroids. Ciba Foundation Symposium 191, Wiley, Chichester, pp. 269-289.
20. Castagnetta L, Miceli MD, Sorci MG, Pfeffer U, Farruggio R, Oliveri G, Calabrò M, Carruba G (1995). Growth of LNCaP cells is stimulated by estradiol via its own receptor. Endocrinology 136: 2309-2319.
21. Connolly JM, Rose DP (1991). Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. The Prostate 19:173-180.
22. Rennie PS, Bruchovsky N, McLoughlin MG, Batzold FH, Dunstan-Adams EE (1983). Kinetic analysis of 5α-reductase isoenzymes in benign prostatic hyperplasia (BPH). J Steroid Biochem 19:169-173.
23. Bruchovski N, Rennie PS, Batzold FH, Goldenberg SL, Fletcher T, McLoughlin MG (1988). Kinetic parameters of 5α-reductase activity in stroma and epithelium of normal, hyperplastic and carcinomatous human prostates. J Clin Endocrinol Metab 67:806-816.
24. Martini L, Celotti F, Lechuga MJ, Melcangi RC, Motta M, Negri-Cesi P, Poletti A, Zoppi S (1990). Androgen metabolism in different target tissues. Ann NY Acad Sci 595:184-198.